14-day Premium Trial Subscription Try For FreeTry Free

Latest Data & Signals Issued

Signal Type Signal Value Data
Score 0.000 78 days ( 0.721 % )
Last Price $20.65 0 %
High/ Low $20.65 - $20.65 0%
Chg 7 Days N/A $20.65 $20.65
Chg 30 Days N/A $20.65 $20.65
Chg 12 mos 46.98 % $14.05 $20.65
Trend - 3 mos -0.1000 % Width: 0.580 %
Trend - 12 mos 92.70 % Width: 68.84 %
Pred. range - 3 mos $20.61 - $20.73 -0.196 % - 0.383 %
Pred. range - 12 mos $31.97 - $53.98 54.81 % - 161.39 %
Short MA avg 3 mos Sell Nov 30, -1 - N/A days
Long MA avg 3 mos Sell Mar 08, 2023 - 57 days
Short/Long MA avg 3 mos Sell Mar 08, 2023 - 57 days
Short MA avg 12 mos Sell Feb 17, 2023 - 69 days
Long MA avg 12 mos Buy Nov 11, 2022 - 135 days
Short/Long MA avg 12 mos Buy Nov 14, 2022 - 134 days
Pivot Short Sell Mar 01, 2023 - 62 days
Bollinger Sell Nov 30, -1 - N/A days
MACD N/A No Dates Stored For This Signal
Click to get the best stock tips daily for free!

About Opiant Pharmaceuticals Inc.

Opiant Pharmaceuticals. Opiant Pharmaceuticals, Inc., a specialty pharmaceutical company, develops medicines for addictions and drug overdose. The company offers NARCAN nasal spray, a treatment to reverse opioid overdoses. Its pipeline of product candidates includes medicines for the treatment for opioid overdose reversal; alcohol use disorders; acute cannabinoid overdose; and opioid use disorders. The company was formerly known as Lightlake Therapeutics Inc. and change... OPNT Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT